⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 16 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 16 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 minutes ago
🛡️ EUSW
🇬🇧
💊 Medicine AT September 24, 2026

Amikacin B. Braun 5 mg/ml Infusionslösung 5 mg/ml (Infusionslösung)

📷 Wikipedia: Amikacin · Source
Amikacin B. Braun 5 mg/ml Infusionslösung 5 mg/ml (Infusionslösung)
📷 Wikipedia: Amikacin · Source

🚫 Parallel export ban active

ATC
J01GB06
Reason
Verzögerung bei der Herstellung
Marketing authorisation holder
B. Braun Melsungen AG, Carl-Braun-Straße 1, 34212 Melsungen, Federal Republic of Germany
Affected packs
1000 ml Schachtel, Flasche [Nicht verfügbar, since 2026-09-16, resupply 2026-10-30]
⚠️
Shortage ongoing
AMIKACINSULFAT is currently in short supply in AT.
📈 Timeline
2 days active so far
September 26, 2026 September 27, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.
A plain-language summary will appear here shortly. Read the official notice below.
🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: J01GB06 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: B. Braun Melsungen AG, Carl-Braun-Straße 1, 34212 Melsungen, Federal Republic of Germany · Affected packs: 1000 ml Schachtel, Flasche [Nicht verfügbar, since 2026-09-16, resupply 2026-10-30]

First published
September 24, 2026
Last refreshed by us
18 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Amikacin B. Braun 5 mg/ml Infusionslösung 5 mg/ml (Infusionslösung). 🚫 Parallel export ban active · ATC: J01GB06 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: B. Braun Melsungen AG, Carl-Braun-Straße 1, 34212 Melsungen, Federal Republic of Germany · Affected packs: 1000 ml Schachtel, Flasche [Nicht verfügbar, since 2...
▸ When was this alert issued?
This alert was issued on September 24, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.